Enzo Biochem, Inc. (ENZ) Financial Statements (2024 and earlier)

Company Profile

Business Address 60 EXECUTIVE BLVD
FARMINGDALE, NY 11735
State of Incorp. NY
Fiscal Year End July 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

10/31/2023
MRQ
7/31/2023
1/31/2023
MRQ
7/31/2022
7/31/2021
7/31/2020
7/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments82,3735,05421,60343,50247,86560,146
Cash and cash equivalents82,3735,05421,60313,52447,86560,146
Short-term investments    29,978  
Receivables4,80810,86611,51610,1989,14110,738
Inventory, net of allowances, customer advances and progress billings7,93915,72315,41112,6527,7847,842
Inventory7,93915,72315,41112,6527,7847,842
Prepaid expense  4,7385,8244,2303,9752,727
Other undisclosed current assets3,336     
Total current assets:98,45636,38154,35470,58268,76581,453
Noncurrent Assets
Operating lease, right-of-use asset3,62613,56915,17417,02019,916 
Property, plant and equipment13,08617,42517,25916,58514,48214,254
Intangible assets, net (including goodwill)  7,4527,4527,6967,9908,484
Goodwill  7,4527,4527,4527,4527,452
Intangible assets, net (excluding goodwill)    2445381,032
Disposal group, including discontinued operation, noncurrent assets967     
Other noncurrent assets5,7451,6251,6181,8081,3852,449
Total noncurrent assets:23,42440,07141,50343,10943,77325,187
TOTAL ASSETS:121,88076,45295,857113,691112,538106,640
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,31824,77925,72022,42421,33615,618
Employee-related liabilities4,912   
Accounts payable3,57513,1898,5088,1238,5037,256
Accrued liabilities11,74311,59012,30014,30112,8338,362
Debt2,514549310 7,000 
Disposal group, including discontinued operation21,102     
Other liabilities75  233344391
Other undisclosed current liabilities9806,873(1,480)3,4194,121 
Total current liabilities:39,98932,20124,55026,07632,80116,009
Noncurrent Liabilities
Long-term debt and lease obligation26928916,80618,91421,1644,179
Long-term debt, excluding current maturities2692894,0774,3564,4854,179
Liabilities, other than long-term debt3,16011,13239115192424
Other liabilities   39115192424
Operating lease, liability3,16011,13212,72914,55816,679 
Total noncurrent liabilities:3,42911,42116,84519,02921,3564,603
Total liabilities:43,41843,62241,39545,10554,15720,612
Equity
Equity, attributable to parent78,46232,83054,46268,58658,38186,028
Common stock499487487485479476
Additional paid in capital344,435340,407339,462337,126334,473332,704
Accumulated other comprehensive income1,8782,5293,1511,3521,6812,580
Accumulated deficit(268,350)(310,593)(288,638)(270,377)(278,252)(249,732)
Total equity:78,46232,83054,46268,58658,38186,028
TOTAL LIABILITIES AND EQUITY:121,88076,45295,857113,691112,538106,640

Income Statement (P&L) ($ in thousands)

10/31/2023
TTM
7/31/2023
1/31/2023
TTM
7/31/2022
7/31/2021
7/31/2020
7/31/2019
Revenues31,061(25,951)107,071117,73176,02181,170
Cost of revenue(17,866)(45,799)(65,104)(64,154)(52,251)(60,080)
Cost of goods and services sold  (16,049) (64,154)(52,251)(57,922)
Gross profit:13,19515,03741,96753,57723,77021,090
Operating expenses(36,302)(13,309)(57,474)(52,885)(54,137)(19,357)
Other undisclosed operating income (loss)(1,629)(27,756)500   
Operating income (loss):(24,736)(26,028)(15,007)692(30,367)1,733
Nonoperating income (expense)380(835)(3,254)7,1751,393756
Investment income, nonoperating 132159  1,056
Gain (loss), foreign currency transaction, before tax (381)(2,222)270905(682)
Other nonoperating income (expense)380(586)(1,191)6,905488382
Interest and debt expense(1,122)(6)(10)(16)(35) 
Other undisclosed income from continuing operations before equity method investments, income taxes     489 
Income (loss) from continuing operations before equity method investments, income taxes:(25,478)(26,869)(18,271)7,851(28,520)2,489
Other undisclosed income (loss) from continuing operations before income taxes456581024  
Income (loss) from continuing operations:(25,022)(26,811)(18,261)7,875(28,520)2,489
Income (loss) before gain (loss) on sale of properties:(15,491)(18,261)7,875(28,520)2,489
Loss from discontinued operations(37,321)     
Other undisclosed net loss      
Net income (loss):(62,343)(26,811)(18,261)7,875(28,520)2,489
Other undisclosed net income attributable to parent82,6312    
Net income (loss) available to common stockholders, basic:20,288(26,809)(18,261)7,875(28,520)2,489
Dilutive securities, effect on basic earnings per share    134  
Net income (loss) available to common stockholders, diluted:20,288(26,809)(18,261)8,009(28,520)2,489

Comprehensive Income ($ in thousands)

10/31/2023
TTM
7/31/2023
1/31/2023
TTM
7/31/2022
7/31/2021
7/31/2020
7/31/2019
Net income (loss):(62,343)(26,811)(18,261)7,875(28,520)2,489
Comprehensive income (loss):(62,343)(26,811)(18,261)7,875(28,520)2,489
Other undisclosed comprehensive income (loss), net of tax, attributable to parent81,3582911,799(329)(899)480
Comprehensive income (loss), net of tax, attributable to parent:19,015(26,520)(16,462)7,546(29,419)2,969

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: